Immune triggers preceding neuralgic amyotrophy
Background and purpose Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown. Methods This was a multicentre, prospective, observational, matched case–control study. NA wa...
Gespeichert in:
| Veröffentlicht in: | European journal of neurology Jg. 31; H. 12; S. e16462 - n/a |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
John Wiley & Sons, Inc
01.12.2024
John Wiley and Sons Inc |
| Schlagworte: | |
| ISSN: | 1351-5101, 1468-1331, 1468-1331 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background and purpose
Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown.
Methods
This was a multicentre, prospective, observational, matched case–control study. NA was diagnosed by neuromuscular experts according to validated clinical criteria and electrodiagnostic studies. Clinical data and biological samples of NA patients were collected within 90 days from disease onset between June 2018 and December 2023. All NA patients were asked about prior infection and vaccination in the month before disease onset. Serological tests for hepatitis E virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Epstein–Barr virus, cytomegalovirus, parvovirus B19, varicella‐zoster virus, Borrelia burgdorferi, Mycoplasma pneumoniae and Bartonella henselae were performed in a central laboratory. Each case was matched with a healthy control for age, sex, place of residence and time of blood collection.
Results
Fifty‐seven patients and corresponding controls were included. The mean age was 45 years for both groups. NA onset was preceded by a symptomatic infectious trigger confirmed by microbiological tests in 15/57 (26.3%) patients. Coronavirus disease 2019 vaccination was considered a potential trigger in 7/57 (12.3%) subjects. An acute viral infection was associated with a bilateral involvement of the brachial plexus (p = 0.003, Cramèr's V = 0.43).
Conclusions
Confirmed immune triggers (infection or vaccination) preceded disease onset in 22/57 (38.6%) NA cases. We suggest to test NA patients in the acute phase for intracellular antigens, especially in the case of concomitant bilateral involvement and hepatitis. |
|---|---|
| AbstractList | Background and purpose Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown. Methods This was a multicentre, prospective, observational, matched case–control study. NA was diagnosed by neuromuscular experts according to validated clinical criteria and electrodiagnostic studies. Clinical data and biological samples of NA patients were collected within 90 days from disease onset between June 2018 and December 2023. All NA patients were asked about prior infection and vaccination in the month before disease onset. Serological tests for hepatitis E virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Epstein–Barr virus, cytomegalovirus, parvovirus B19, varicella‐zoster virus, Borrelia burgdorferi, Mycoplasma pneumoniae and Bartonella henselae were performed in a central laboratory. Each case was matched with a healthy control for age, sex, place of residence and time of blood collection. Results Fifty‐seven patients and corresponding controls were included. The mean age was 45 years for both groups. NA onset was preceded by a symptomatic infectious trigger confirmed by microbiological tests in 15/57 (26.3%) patients. Coronavirus disease 2019 vaccination was considered a potential trigger in 7/57 (12.3%) subjects. An acute viral infection was associated with a bilateral involvement of the brachial plexus (p = 0.003, Cramèr's V = 0.43). Conclusions Confirmed immune triggers (infection or vaccination) preceded disease onset in 22/57 (38.6%) NA cases. We suggest to test NA patients in the acute phase for intracellular antigens, especially in the case of concomitant bilateral involvement and hepatitis. Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown. This was a multicentre, prospective, observational, matched case-control study. NA was diagnosed by neuromuscular experts according to validated clinical criteria and electrodiagnostic studies. Clinical data and biological samples of NA patients were collected within 90 days from disease onset between June 2018 and December 2023. All NA patients were asked about prior infection and vaccination in the month before disease onset. Serological tests for hepatitis E virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Epstein-Barr virus, cytomegalovirus, parvovirus B19, varicella-zoster virus, Borrelia burgdorferi, Mycoplasma pneumoniae and Bartonella henselae were performed in a central laboratory. Each case was matched with a healthy control for age, sex, place of residence and time of blood collection. Fifty-seven patients and corresponding controls were included. The mean age was 45 years for both groups. NA onset was preceded by a symptomatic infectious trigger confirmed by microbiological tests in 15/57 (26.3%) patients. Coronavirus disease 2019 vaccination was considered a potential trigger in 7/57 (12.3%) subjects. An acute viral infection was associated with a bilateral involvement of the brachial plexus (p = 0.003, Cramèr's V = 0.43). Confirmed immune triggers (infection or vaccination) preceded disease onset in 22/57 (38.6%) NA cases. We suggest to test NA patients in the acute phase for intracellular antigens, especially in the case of concomitant bilateral involvement and hepatitis. Background and purpose Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown. Methods This was a multicentre, prospective, observational, matched case–control study. NA was diagnosed by neuromuscular experts according to validated clinical criteria and electrodiagnostic studies. Clinical data and biological samples of NA patients were collected within 90 days from disease onset between June 2018 and December 2023. All NA patients were asked about prior infection and vaccination in the month before disease onset. Serological tests for hepatitis E virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Epstein–Barr virus, cytomegalovirus, parvovirus B19, varicella‐zoster virus, Borrelia burgdorferi, Mycoplasma pneumoniae and Bartonella henselae were performed in a central laboratory. Each case was matched with a healthy control for age, sex, place of residence and time of blood collection. Results Fifty‐seven patients and corresponding controls were included. The mean age was 45 years for both groups. NA onset was preceded by a symptomatic infectious trigger confirmed by microbiological tests in 15/57 (26.3%) patients. Coronavirus disease 2019 vaccination was considered a potential trigger in 7/57 (12.3%) subjects. An acute viral infection was associated with a bilateral involvement of the brachial plexus (p = 0.003, Cramèr's V = 0.43). Conclusions Confirmed immune triggers (infection or vaccination) preceded disease onset in 22/57 (38.6%) NA cases. We suggest to test NA patients in the acute phase for intracellular antigens, especially in the case of concomitant bilateral involvement and hepatitis. Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown.BACKGROUND AND PURPOSEInfections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown.This was a multicentre, prospective, observational, matched case-control study. NA was diagnosed by neuromuscular experts according to validated clinical criteria and electrodiagnostic studies. Clinical data and biological samples of NA patients were collected within 90 days from disease onset between June 2018 and December 2023. All NA patients were asked about prior infection and vaccination in the month before disease onset. Serological tests for hepatitis E virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Epstein-Barr virus, cytomegalovirus, parvovirus B19, varicella-zoster virus, Borrelia burgdorferi, Mycoplasma pneumoniae and Bartonella henselae were performed in a central laboratory. Each case was matched with a healthy control for age, sex, place of residence and time of blood collection.METHODSThis was a multicentre, prospective, observational, matched case-control study. NA was diagnosed by neuromuscular experts according to validated clinical criteria and electrodiagnostic studies. Clinical data and biological samples of NA patients were collected within 90 days from disease onset between June 2018 and December 2023. All NA patients were asked about prior infection and vaccination in the month before disease onset. Serological tests for hepatitis E virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Epstein-Barr virus, cytomegalovirus, parvovirus B19, varicella-zoster virus, Borrelia burgdorferi, Mycoplasma pneumoniae and Bartonella henselae were performed in a central laboratory. Each case was matched with a healthy control for age, sex, place of residence and time of blood collection.Fifty-seven patients and corresponding controls were included. The mean age was 45 years for both groups. NA onset was preceded by a symptomatic infectious trigger confirmed by microbiological tests in 15/57 (26.3%) patients. Coronavirus disease 2019 vaccination was considered a potential trigger in 7/57 (12.3%) subjects. An acute viral infection was associated with a bilateral involvement of the brachial plexus (p = 0.003, Cramèr's V = 0.43).RESULTSFifty-seven patients and corresponding controls were included. The mean age was 45 years for both groups. NA onset was preceded by a symptomatic infectious trigger confirmed by microbiological tests in 15/57 (26.3%) patients. Coronavirus disease 2019 vaccination was considered a potential trigger in 7/57 (12.3%) subjects. An acute viral infection was associated with a bilateral involvement of the brachial plexus (p = 0.003, Cramèr's V = 0.43).Confirmed immune triggers (infection or vaccination) preceded disease onset in 22/57 (38.6%) NA cases. We suggest to test NA patients in the acute phase for intracellular antigens, especially in the case of concomitant bilateral involvement and hepatitis.CONCLUSIONSConfirmed immune triggers (infection or vaccination) preceded disease onset in 22/57 (38.6%) NA cases. We suggest to test NA patients in the acute phase for intracellular antigens, especially in the case of concomitant bilateral involvement and hepatitis. |
| Author | Scheidegger, Olivier Petrini, Orlando Jung, Hans H. Schreiner, Bettina Ripellino, Paolo Hundsberger, Thomas Peyer, Anne‐Kathrin Zezza, Giulia Sparasci, Davide Gowland, Peter Dietmann, Anelia Wilder‐Smith, Einar Tsouni, Pinelopi Pianezzi, Enea Vicino, Alex Humm, Andrea Monika Lascano, Agustina Maria Kuntzer, Thierry Niederhauser, Christoph Martinetti‐Lucchini, Gladys Gobbi, Claudio Décard, Bernhard Friedrich Schilg‐Hafer, Lenka Fontana, Stefano |
| AuthorAffiliation | 1 Department of Neurology Neurocenter of Southern Switzerland EOC Lugano Switzerland 3 Department of Neurology University and Hospital Zurich Zurich Switzerland 11 Laboratory of Microbiology EOC Bellinzona Switzerland 6 Neurology Division, Department of Clinical Neuroscience, University Hospitals of Geneva and Faculty of Medicine University of Geneva Geneva Switzerland 2 Department of Neurology Cantonal Hospital St Gallen Switzerland 7 Nerve‐Muscle Unit, Neurology Service, Department of Clinical Neurosciences Lausanne University Hospital and University of Lausanne Lausanne Switzerland 5 Department of Neurology University Hospital and University of Basel Basel Switzerland 12 University of Applied Sciences and Arts of Southern Switzerland Bellinzona Switzerland 15 Institute for Infectious Diseases University of Bern Bern Switzerland 9 Department of Neurology Hôpital du Valais Sion Switzerland 8 Cantonal Hospital Lucerne Switzerland 4 Department of Neurology, Inselspital Bern University Hospital and |
| AuthorAffiliation_xml | – name: 11 Laboratory of Microbiology EOC Bellinzona Switzerland – name: 12 University of Applied Sciences and Arts of Southern Switzerland Bellinzona Switzerland – name: 6 Neurology Division, Department of Clinical Neuroscience, University Hospitals of Geneva and Faculty of Medicine University of Geneva Geneva Switzerland – name: 5 Department of Neurology University Hospital and University of Basel Basel Switzerland – name: 10 Neurology Unit, Department of Medicine HFR Fribourg Cantonal Hospital Fribourg Switzerland – name: 2 Department of Neurology Cantonal Hospital St Gallen Switzerland – name: 4 Department of Neurology, Inselspital Bern University Hospital and University of Bern Bern Switzerland – name: 14 Interregional Blood Transfusion SRC Bern Switzerland – name: 8 Cantonal Hospital Lucerne Switzerland – name: 9 Department of Neurology Hôpital du Valais Sion Switzerland – name: 13 Blood Transfusion Service SRC Southern Switzerland Lugano Switzerland – name: 15 Institute for Infectious Diseases University of Bern Bern Switzerland – name: 1 Department of Neurology Neurocenter of Southern Switzerland EOC Lugano Switzerland – name: 7 Nerve‐Muscle Unit, Neurology Service, Department of Clinical Neurosciences Lausanne University Hospital and University of Lausanne Lausanne Switzerland – name: 16 Faculty of Biomedical Sciences Università della Svizzera Italiana Lugano Switzerland – name: 3 Department of Neurology University and Hospital Zurich Zurich Switzerland |
| Author_xml | – sequence: 1 givenname: Davide orcidid: 0000-0002-6190-1633 surname: Sparasci fullname: Sparasci, Davide organization: Neurocenter of Southern Switzerland EOC – sequence: 2 givenname: Lenka surname: Schilg‐Hafer fullname: Schilg‐Hafer, Lenka organization: Cantonal Hospital – sequence: 3 givenname: Bettina surname: Schreiner fullname: Schreiner, Bettina organization: University and Hospital Zurich – sequence: 4 givenname: Olivier surname: Scheidegger fullname: Scheidegger, Olivier organization: Bern University Hospital and University of Bern – sequence: 5 givenname: Anne‐Kathrin surname: Peyer fullname: Peyer, Anne‐Kathrin organization: University Hospital and University of Basel – sequence: 6 givenname: Agustina Maria orcidid: 0000-0001-7572-8811 surname: Lascano fullname: Lascano, Agustina Maria organization: University of Geneva – sequence: 7 givenname: Alex orcidid: 0000-0001-6420-8124 surname: Vicino fullname: Vicino, Alex organization: Lausanne University Hospital and University of Lausanne – sequence: 8 givenname: Bernhard Friedrich surname: Décard fullname: Décard, Bernhard Friedrich organization: Cantonal Hospital – sequence: 9 givenname: Pinelopi surname: Tsouni fullname: Tsouni, Pinelopi organization: Hôpital du Valais – sequence: 10 givenname: Andrea Monika surname: Humm fullname: Humm, Andrea Monika organization: HFR Fribourg Cantonal Hospital – sequence: 11 givenname: Enea surname: Pianezzi fullname: Pianezzi, Enea organization: Laboratory of Microbiology EOC – sequence: 12 givenname: Giulia surname: Zezza fullname: Zezza, Giulia organization: Laboratory of Microbiology EOC – sequence: 13 givenname: Thomas surname: Hundsberger fullname: Hundsberger, Thomas organization: Cantonal Hospital – sequence: 14 givenname: Anelia orcidid: 0000-0002-8949-0645 surname: Dietmann fullname: Dietmann, Anelia organization: Bern University Hospital and University of Bern – sequence: 15 givenname: Hans H. surname: Jung fullname: Jung, Hans H. organization: University and Hospital Zurich – sequence: 16 givenname: Thierry surname: Kuntzer fullname: Kuntzer, Thierry organization: Lausanne University Hospital and University of Lausanne – sequence: 17 givenname: Einar surname: Wilder‐Smith fullname: Wilder‐Smith, Einar organization: Cantonal Hospital – sequence: 18 givenname: Gladys surname: Martinetti‐Lucchini fullname: Martinetti‐Lucchini, Gladys organization: Laboratory of Microbiology EOC – sequence: 19 givenname: Orlando surname: Petrini fullname: Petrini, Orlando organization: University of Applied Sciences and Arts of Southern Switzerland – sequence: 20 givenname: Stefano surname: Fontana fullname: Fontana, Stefano organization: Interregional Blood Transfusion SRC – sequence: 21 givenname: Peter surname: Gowland fullname: Gowland, Peter organization: Interregional Blood Transfusion SRC – sequence: 22 givenname: Christoph surname: Niederhauser fullname: Niederhauser, Christoph organization: University of Bern – sequence: 23 givenname: Claudio orcidid: 0000-0002-7554-0664 surname: Gobbi fullname: Gobbi, Claudio organization: Università della Svizzera Italiana – sequence: 24 givenname: Paolo orcidid: 0000-0002-8662-9656 surname: Ripellino fullname: Ripellino, Paolo email: paolo.ripellino@eoc.ch organization: Università della Svizzera Italiana |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39364568$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUFPHCEUx0mjqbp66BdoNumlHmaXBwzDnJrGrNZko5f2TJB5M2JmYAszNvvti641amI5AAm_98_v8Y7Ing8eCfkEdAF5LdHjAqSQ7AM5BCFVAZzDXr7zEooSKByQo5TuKKWsYvQjOeA1l6KU6pAsLodh8jgfo-s6jGm-iWixcb6be5yi6Ttn52bYhjGGze32mOy3pk948nTOyK_z1c-zH8X6-uLy7Pu6sEIIVjAhgcpWAqecNca0SnIU2FqDtQKEBuqK3bCWqqrltWTZsamQs8qiMbUxfEa-7XI3082AjUU_Zhe9iW4wcauDcfr1i3e3ugv3GqAshaogJ3x9Sojh94Rp1INLFvveeAxT0hyAqSyYzWbkyxv0LkzR5_4yxaRieVeZ-vxS6dnl319m4HQH2BhSitg-I0D1w5x0npN-nFNml29Y60YzuvDQjev_V_HH9bh9P1qvrla7ir-5CqKx |
| CitedBy_id | crossref_primary_10_1016_j_mehy_2025_111760 |
| Cites_doi | 10.1016/j.ejpn.2003.08.006 10.1007/s00415-002-0868-0 10.1097/CND.0b013e318175a5ca 10.1212/NXI.0000000000000643 10.1016/s0736-4679(99)00189-4 10.3390/vaccines9091022 10.1093/rheumatology/34.5.480 10.1111/ene.16030 10.1177/03000605231187939 10.1258/ijsa.2011.011176 10.1002/mus.25008 10.1186/s12879-018-3137-2 10.1212/01.wnl.0000118282.17433.31 10.1016/j.jiac.2019.02.015 10.1136/ard.57.4.262 10.1212/wnl.0000000000200014 10.1371/journal.pone.0128361 10.1080/13554794.2022.2085118 10.1159/000330571 10.1007/BF02125623 10.3390/pathogens11010066 10.1093/brain/awh722 10.1001/archneur.1972.00490140013004 10.1016/s0140-6736(48)90611-4 10.3390/biomedicines11030837 10.1016/j.jbspin.2008.07.013 10.7326/0003-4819-107-6-849 10.1136/bmj.296.6626.896 10.1002/14651858.cd006976.pub2 10.1212/WNL.0000000000004297 10.1056/NEJM198302243080819 10.1136/jnnp.2009.191940 10.1212/WNL.0000000000000112 10.1097/NRL.0b013e31820038cd 10.1016/0140-6736(93)91635-y 10.1097/WCO.0000000000000968 |
| ContentType | Journal Article |
| Copyright | 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2024 The Author(s). published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. – notice: 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. – notice: 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 5PM |
| DOI | 10.1111/ene.16462 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley-Blackwell Open Access Collection url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Immune triggers in NA |
| EISSN | 1468-1331 |
| EndPage | n/a |
| ExternalDocumentID | PMC11554871 39364568 10_1111_ene_16462 ENE16462 |
| Genre | researchArticle Multicenter Study Journal Article Observational Study |
| GrantInformation_xml | – fundername: Neuromuscular Research Association Basel – fundername: Foundation for the Advancement of Neurology, Lausanne – fundername: Baasch‐Medicus Stiftung, Zurich – fundername: Baasch-Medicus Stiftung, Zurich |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 169 1OB 1OC 24P 29G 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFGKR AFKRA AFPWT AFRAH AFWVQ AFZJQ AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F5P FEDTE FUBAC FYBCS FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIG RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ TEORI UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AGQPQ AGXDD AIDQK AIDYY AIQQE CITATION GROUPED_DOAJ O8X PHGZM WIN CGR CUY CVF ECM EIF NPM 7TK 7U7 C1K K9. 7X8 5PM |
| ID | FETCH-LOGICAL-c4442-246106f613032daaf863e4efcae981e1d1972b2f087f3962510d7e327ceaa9aa3 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001325693800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1351-5101 1468-1331 |
| IngestDate | Tue Nov 04 02:05:19 EST 2025 Thu Oct 02 07:13:28 EDT 2025 Sat Nov 29 14:34:49 EST 2025 Mon Jul 21 05:54:47 EDT 2025 Sat Nov 29 07:32:29 EST 2025 Tue Nov 18 22:14:15 EST 2025 Wed Jan 22 17:12:50 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | infection neuralgic amyotrophy immune trigger Parsonage–Turner syndrome vaccination |
| Language | English |
| License | Attribution 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4442-246106f613032daaf863e4efcae981e1d1972b2f087f3962510d7e327ceaa9aa3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-6190-1633 0000-0002-8662-9656 0000-0001-7572-8811 0000-0001-6420-8124 0000-0002-7554-0664 0000-0002-8949-0645 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fene.16462 |
| PMID | 39364568 |
| PQID | 3126823128 |
| PQPubID | 1066358 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11554871 proquest_miscellaneous_3112861386 proquest_journals_3126823128 pubmed_primary_39364568 crossref_primary_10_1111_ene_16462 crossref_citationtrail_10_1111_ene_16462 wiley_primary_10_1111_ene_16462_ENE16462 |
| PublicationCentury | 2000 |
| PublicationDate | December 2024 |
| PublicationDateYYYYMMDD | 2024-12-01 |
| PublicationDate_xml | – month: 12 year: 2024 text: December 2024 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
| PublicationTitle | European journal of neurology |
| PublicationTitleAlternate | Eur J Neurol |
| PublicationYear | 2024 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
| References | 2023; 31 2021; 9 2023; 51 2004; 62 2023; 11 2011; 82 1995; 34 1983; 4 1987; 107 2015; 10 2017; 89 2008; 9 2016; 53 2011; 17 2011; 3 2014; 82 2022; 28 1972; 27 1993; 342 2020; 7 2018; 18 2009; 2009 2000; 18 2009; 76 2021; 34 1948; 1 2003; 7 2019; 25 2002; 249 1988; 296 2022; 98 2022; 11 2006; 129 2012; 23 1983; 308 1998; 57 e_1_2_11_10_1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_36_1 e_1_2_11_14_1 e_1_2_11_13_1 e_1_2_11_35_1 e_1_2_11_12_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_2_1 e_1_2_11_21_1 e_1_2_11_20_1 e_1_2_11_25_1 e_1_2_11_24_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_18_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_37_1 e_1_2_11_19_1 |
| References_xml | – volume: 17 start-page: 24 issue: 1 year: 2011 end-page: 27 article-title: Acute brachial diplegia due to Lyme disease publication-title: Neurologist – volume: 7 issue: 1 year: 2020 article-title: Neurologic complications of acute hepatitis E virus infection publication-title: Neurol Neuroimmunol Neuroinflammation – volume: 342 start-page: 503 issue: 8869 year: 1993 end-page: 504 article-title: Neuralgic amyotrophy after parvovirus B19 infection publication-title: Lancet – volume: 296 start-page: 896 issue: 6626 year: 1988 article-title: Brachial plexus neuropathy associated with human parvovirus infection publication-title: BMJ – volume: 249 start-page: 1605 issue: 11 year: 2002 end-page: 1607 article-title: Neuralgic amyotrophy as a manifestation of infectious mononucleosis publication-title: J Neurol – volume: 9 start-page: 402 issue: 4 year: 2008 end-page: 406 article-title: Brachial neuritis with bilateral diaphragmatic paralysis following herpes zoster: a case report publication-title: J Clin Neuromuscul Dis – volume: 23 start-page: 143 issue: 2 year: 2012 end-page: 144 article-title: Brachial plexus neuritis in the context of acute HIV seroconversion illness: a case report publication-title: Int J STD AIDS – volume: 9 start-page: 1022 issue: 9 year: 2021 article-title: Reporting of acute inflammatory neuropathies with COVID‐19 vaccines: subgroup disproportionality analyses in vigibase publication-title: Vaccine – volume: 89 start-page: 909 issue: 9 year: 2017 end-page: 917 article-title: Clinical phenotype and outcome of hepatitis E virus‐associated neuralgic amyotrophy publication-title: Neurology – volume: 18 start-page: 177 issue: 2 year: 2000 end-page: 179 article-title: Viral brachial neuritis in emergency medicine publication-title: J Emerg Med – volume: 53 start-page: 337 issue: 3 year: 2016 end-page: 350 article-title: Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment publication-title: Muscle Nerve – volume: 82 start-page: 707 issue: 6 year: 2011 end-page: 708 article-title: Neuralgic amyotrophy associated with infection publication-title: J Neurol Neurosurg Psychiatry – volume: 34 start-page: 605 issue: 5 year: 2021 end-page: 612 article-title: Neuralgic amyotrophy publication-title: Curr Opin Neurol – volume: 129 start-page: 438 issue: 2 year: 2006 end-page: 450 article-title: The clinical spectrum of neuralgic amyotrophy in 246 cases publication-title: Brain – volume: 51 issue: 7 year: 2023 article-title: Association of Parsonage–Turner syndrome with COVID‐19 infection and vaccination: a systematic review publication-title: J Int Med Res – volume: 27 start-page: 109 issue: 2 year: 1972 article-title: Natural history of brachial plexus neuropathy: report on 99 patients publication-title: Arch Neurol – volume: 4 start-page: 431 issue: 4 year: 1983 end-page: 437 article-title: So‐called neuralgic amyotrophy: clinical features and long term follow‐up publication-title: Ital J Neurol Sci – volume: 18 start-page: 238 issue: 1 year: 2018 article-title: Varicella zoster virus infections in neurological patients: a clinical study publication-title: BMC Infect Dis – volume: 11 start-page: 837 issue: 3 year: 2023 article-title: Parsonage–Turner syndrome following SARS‐CoV‐2 infection: a systematic review publication-title: Biomedicine – volume: 31 issue: 1 year: 2023 article-title: Neuropathies related to hepatitis E virus infection: a prospective, matched case–control study publication-title: Eur J Neurol – volume: 57 start-page: 262 issue: 4 year: 1998 end-page: 263 article-title: Neuralgic amyotrophy and polyarthritis caused by parvovirus B19 infection publication-title: Ann Rheum Dis – volume: 308 start-page: 461 issue: 8 year: 1983 article-title: Cytomegalovirus infection complicated by neuralgic amyotrophy publication-title: N Engl J Med – volume: 82 start-page: 498 issue: 6 year: 2014 end-page: 503 article-title: Neuralgic amyotrophy and hepatitis E virus infection publication-title: Neurology – volume: 10 issue: 5 year: 2015 article-title: Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting—a prospective cohort study publication-title: PLoS One – volume: 2009 issue: 3 year: 2009 article-title: Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis) publication-title: Cochrane Database Syst Rev – volume: 3 start-page: 165 issue: 2 year: 2011 end-page: 171 article-title: Parsonage–Turner syndrome rather than zoster neuritis? publication-title: Case Rep Neurol – volume: 76 start-page: 202 issue: 2 year: 2009 end-page: 204 article-title: Parsonage–Turner syndrome revealing Lyme borreliosis publication-title: Joint Bone Spine – volume: 34 start-page: 480 issue: 5 year: 1995 end-page: 481 article-title: Brachial plexitis in a patient with acute parvovirus B19 infection publication-title: Br J Rheumatol – volume: 1 start-page: 973 issue: 6513 year: 1948 end-page: 978 article-title: Neuralgic amyotrophy; the shoulder‐girdle syndrome publication-title: Lancet Lond Engl – volume: 7 start-page: 413 issue: 6 year: 2003 end-page: 415 article-title: Brachial neuritis following infection with Epstein–Barr virus publication-title: Eur J Paediatr Neurol – volume: 107 start-page: 849 issue: 6 year: 1987 end-page: 851 article-title: Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash publication-title: Ann Intern Med – volume: 28 start-page: 320 issue: 3 year: 2022 end-page: 322 article-title: Neuralgic amyotrophy triggered by cytomegalovirus: to be aware of this clinical diagnosis publication-title: Neurocase – volume: 62 start-page: 1234 issue: 7 year: 2004 end-page: 1235 article-title: Neuralgic amyotrophy precipitated by Epstein–Barr virus publication-title: Neurology – volume: 98 start-page: 597 issue: 14 year: 2022 end-page: 600 article-title: Pearls and oysters: bilateral mononeuropathic neuralgic amyotrophy triggered by infection responsive to immunoglobulin publication-title: Neurology – volume: 25 start-page: 556 issue: 7 year: 2019 end-page: 558 article-title: Visceral disseminated varicella zoster virus infection with brachial plexus neuritis detected by fluorodeoxyglucose positron emission tomography and computed tomography publication-title: J Infect Chemother off J Jpn Soc Chemother – volume: 11 start-page: 66 issue: 1 year: 2022 article-title: Detection of circulating VZV‐glycoprotein E‐specific antibodies by chemiluminescent immunoassay (CLIA) for varicella‐zoster diagnosis publication-title: Pathog Basel Switz – ident: e_1_2_11_16_1 doi: 10.1016/j.ejpn.2003.08.006 – ident: e_1_2_11_15_1 doi: 10.1007/s00415-002-0868-0 – ident: e_1_2_11_23_1 doi: 10.1097/CND.0b013e318175a5ca – ident: e_1_2_11_11_1 doi: 10.1212/NXI.0000000000000643 – ident: e_1_2_11_26_1 doi: 10.1016/s0736-4679(99)00189-4 – ident: e_1_2_11_35_1 doi: 10.3390/vaccines9091022 – ident: e_1_2_11_20_1 doi: 10.1093/rheumatology/34.5.480 – ident: e_1_2_11_10_1 doi: 10.1111/ene.16030 – ident: e_1_2_11_34_1 doi: 10.1177/03000605231187939 – ident: e_1_2_11_32_1 doi: 10.1258/ijsa.2011.011176 – ident: e_1_2_11_4_1 doi: 10.1002/mus.25008 – ident: e_1_2_11_25_1 doi: 10.1186/s12879-018-3137-2 – ident: e_1_2_11_17_1 doi: 10.1212/01.wnl.0000118282.17433.31 – ident: e_1_2_11_24_1 doi: 10.1016/j.jiac.2019.02.015 – ident: e_1_2_11_19_1 doi: 10.1136/ard.57.4.262 – ident: e_1_2_11_30_1 doi: 10.1212/wnl.0000000000200014 – ident: e_1_2_11_3_1 doi: 10.1371/journal.pone.0128361 – ident: e_1_2_11_28_1 doi: 10.1080/13554794.2022.2085118 – ident: e_1_2_11_22_1 doi: 10.1159/000330571 – ident: e_1_2_11_6_1 doi: 10.1007/BF02125623 – ident: e_1_2_11_8_1 doi: 10.3390/pathogens11010066 – ident: e_1_2_11_2_1 doi: 10.1093/brain/awh722 – ident: e_1_2_11_5_1 doi: 10.1001/archneur.1972.00490140013004 – ident: e_1_2_11_9_1 doi: 10.1016/s0140-6736(48)90611-4 – ident: e_1_2_11_33_1 doi: 10.3390/biomedicines11030837 – ident: e_1_2_11_13_1 doi: 10.1016/j.jbspin.2008.07.013 – ident: e_1_2_11_31_1 doi: 10.7326/0003-4819-107-6-849 – ident: e_1_2_11_21_1 doi: 10.1136/bmj.296.6626.896 – ident: e_1_2_11_7_1 doi: 10.1002/14651858.cd006976.pub2 – ident: e_1_2_11_37_1 doi: 10.1212/WNL.0000000000004297 – ident: e_1_2_11_27_1 doi: 10.1056/NEJM198302243080819 – ident: e_1_2_11_29_1 doi: 10.1136/jnnp.2009.191940 – ident: e_1_2_11_12_1 doi: 10.1212/WNL.0000000000000112 – ident: e_1_2_11_14_1 doi: 10.1097/NRL.0b013e31820038cd – ident: e_1_2_11_18_1 doi: 10.1016/0140-6736(93)91635-y – ident: e_1_2_11_36_1 doi: 10.1097/WCO.0000000000000968 |
| SSID | ssj0002720 |
| Score | 2.44862 |
| Snippet | Background and purpose
Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type... Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the... Background and purpose Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e16462 |
| SubjectTerms | Adult Aged Biological properties Biological samples Brachial Plexus Neuritis - etiology Case-Control Studies Coronaviruses COVID-19 COVID-19 - complications COVID-19 - immunology COVID-19 Vaccines - immunology Cytomegalovirus Disease control Epstein-Barr virus Female Hepatitis HIV Human immunodeficiency virus Humans immune trigger Immunization Immunology infection Infections Male Middle Aged neuralgic amyotrophy Neuromuscular system Neuropathies Original Parsonage–Turner syndrome Parvoviruses Prospective Studies Respiratory diseases Serological tests Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Vaccination Varicella Viral diseases Viral infections |
| Title | Immune triggers preceding neuralgic amyotrophy |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fene.16462 https://www.ncbi.nlm.nih.gov/pubmed/39364568 https://www.proquest.com/docview/3126823128 https://www.proquest.com/docview/3112861386 https://pubmed.ncbi.nlm.nih.gov/PMC11554871 |
| Volume | 31 |
| WOSCitedRecordID | wos001325693800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: DOA dateStart: 20240101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: 7X7 dateStart: 20240101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: BENPR dateStart: 20240101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley-Blackwell Open Access Collection customDbUrl: eissn: 1468-1331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002720 issn: 1351-5101 databaseCode: 24P dateStart: 20240101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1RS9xAEB5ES_Gl2lbtWT1i6YMvkdvsXnaDT1XvqFDDIZXeW9gksypoTu7OQv-9M5tc8LBCoS8hy86SbGZndiaz8w3AV5HkpUKpQ80ZMko6DA06HSKnZRo0pZHOF5vQaWrG42S0AseLXJgaH6L94caS4fU1C7jNZ8-EnFTBEYNjkf5dE0IartsQqVGrhjnA6L2tvgh54TWwQnyMpx26vBm9sDBfHpR8bsD6HWi48V_vvgnvGsMz-FavlPewgtUHeHvRhNY_wtE5Z4pgMCd3_ZpswuCBdKHf2QLGvLR3pCIDe_9nMp9OiDVbcDUc_Dz9HjbFFMJCKU7BYWD12LG7IKPSWmdiiQpdYTExAkXJ9cfyyPWMdjIhr0j0So0y0gVam1grt2G1mlT4CQIse4WIUZVR36p-ofKksCY3uUbnciWxA4eLr5oVDdI4F7y4yxYeB80_8_PvwJeW9KGG1_gb0d6CNVkjYbNMiijmEGZkOnDQdpNscMDDVjh5ZBrqphmbuAM7NSfbp8iEA7AxjTZLPG4JGHd7uae6vfH424JtMHI0aZ6eya-_eTZIB_5m999JP8N6RIZTfWRmD1bn00fchzfF7_ntbNr1a5yueqz91XRh7WSQji67_m8Ctc4uh1c_qPXrPH0C-4kF2g |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8RADA6iol58P9ZnFQ9eKtvObDsFLyIrLmrxoOitTNuMCtqVfQj-e5Npt7ioIHgrTIY2zSSTTCZfAA69KM0litANuUJGCoOuQhO6yGWZClWuhLHNJsI4Vg8P0c0EnIxqYUp8iPrAjTXD2mtWcD6Q_qLlZAuOGR2LDPCUJEeDGzfcd-LaDnOG0YZbLc_llVfhCvE9nnrq-G70zcX8flPyqwdrt6Dzhf99_CLMV66nc1qulSWYwGIZZq6r5PoKHHe4VgSdAQXsj-QVOm9kDe3e5jDqpX4hI-no14_uoNcl4azC3Xn79uzCrdopuJmUXITD0OqB4YBB-LnWRgUCJZpMY6Q89HLuQJb6pqlCIyKKi7xmHqLwwwy1jrQWazBZdAvcAAfzZuYFKHO_pWUrk2mUaZWqNERjUimwAUej35pkFdY4t7x4SUYxB_GfWP4bcFCTvpUAGz8RbY9kk1Q61k-E5wecxPRVA_brYdIOTnnoArtDpqFh4lgFDVgvRVm_RUScgg1othoTck3AyNvjI8Xzk0Xg9tgLo1CT-LRS_v3Lk3bctg-bfyfdg9mL2-ur5KoTX27BnE9uVHmBZhsmB70h7sB09j547vd27YL_BHPuAyU |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8NADA-yifji98d0ahUffKmsvVt7BV9ENxR1iCj4Vq5tTgXtxpyC_73JtSsOFQTfCpejzeWSS5rLLwD7XpRkEkXohlwhI4VBV6EJXeSyTIUqU8LYZhNhr6fu76PrKTga18IU-BDVDzfWDGuvWcFxkJkvWk624JDRscgA1yU3kalB_fSme3dZWWLOMdqAq-25vPdKZCG-yVNNnjyPvjmZ3-9KfvVh7SHUnf_f5y_AXOl8OsfFblmEKcyXYOaqTK8vw-E5V4ugM6KQ_YH8QmdA9tCebg7jXupnMpOOfvnoj4Z9Es8K3HU7tydnbtlQwU2l5DIcBlcPDIcMws-0NioQKNGkGiPloZdxD7LENy0VGkELSmuWhSj8MEWtI63FKtTyfo7r4GDWSr0AZea3tWynMolSrRKVhGhMIgU24GC8rHFaoo1z04vneBx1EP-x5b8BexXpoIDY-ImoOZZNXGrZayw8P-A0pq8asFsNk35w0kPn2H9jGhomjlXQgLVClNVbRMRJ2IBmqwkhVwSMvT05kj89Wgxuj_0wCjaJTyvl37887vQ69mHj76Q7MHN92o0vz3sXmzDrkx9V3KBpQm00fMMtmE7fR0-vw-1yx38CFucDzg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immune+triggers+preceding+neuralgic+amyotrophy&rft.jtitle=European+journal+of+neurology&rft.au=Sparasci%2C+Davide&rft.au=Schilg%E2%80%90Hafer%2C+Lenka&rft.au=Schreiner%2C+Bettina&rft.au=Scheidegger%2C+Olivier&rft.date=2024-12-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1351-5101&rft.eissn=1468-1331&rft.volume=31&rft.issue=12&rft_id=info:doi/10.1111%2Fene.16462&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-5101&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-5101&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-5101&client=summon |